BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 23995678)

  • 1. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2.
    Herzog BH; Fu J; Wilson SJ; Hess PR; Sen A; McDaniel JM; Pan Y; Sheng M; Yago T; Silasi-Mansat R; McGee S; May F; Nieswandt B; Morris AJ; Lupu F; Coughlin SR; McEver RP; Chen H; Kahn ML; Xia L
    Nature; 2013 Oct; 502(7469):105-9. PubMed ID: 23995678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2.
    Acton SE; Astarita JL; Malhotra D; Lukacs-Kornek V; Franz B; Hess PR; Jakus Z; Kuligowski M; Fletcher AL; Elpek KG; Bellemare-Pelletier A; Sceats L; Reynoso ED; Gonzalez SF; Graham DB; Chang J; Peters A; Woodruff M; Kim YA; Swat W; Morita T; Kuchroo V; Carroll MC; Kahn ML; Wucherpfennig KW; Turley SJ
    Immunity; 2012 Aug; 37(2):276-89. PubMed ID: 22884313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology.
    Suzuki-Inoue K; Tsukiji N
    Curr Opin Hematol; 2024 May; 31(3):130-139. PubMed ID: 38359177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
    Suzuki-Inoue K; Osada M; Ozaki Y
    J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.
    Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML
    Blood; 2010 Jul; 116(4):661-70. PubMed ID: 20363774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLEC-2 is required for development and maintenance of lymph nodes.
    Bénézech C; Nayar S; Finney BA; Withers DR; Lowe K; Desanti GE; Marriott CL; Watson SP; Caamaño JH; Buckley CD; Barone F
    Blood; 2014 May; 123(20):3200-7. PubMed ID: 24532804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of podoplanin in vascular development and homeostasis.
    Pan Y; Xia L
    Front Med; 2015 Dec; 9(4):421-30. PubMed ID: 26498027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal Deletion of Podoplanin in Lymphatic Endothelium Results in Blood Filling of the Lymphatic System and Impairs Dendritic Cell Migration to Lymph Nodes.
    Bianchi R; Russo E; Bachmann SB; Proulx ST; Sesartic M; Smaadahl N; Watson SP; Buckley CD; Halin C; Detmar M
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):108-117. PubMed ID: 27810998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity.
    Bianchi R; Fischer E; Yuen D; Ernst E; Ochsenbein AM; Chen L; Otto VI; Detmar M
    J Biol Chem; 2014 Jul; 289(30):21016-27. PubMed ID: 24907275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells control fibroblastic reticular network tension and lymph node expansion.
    Acton SE; Farrugia AJ; Astarita JL; Mourão-Sá D; Jenkins RP; Nye E; Hooper S; van Blijswijk J; Rogers NC; Snelgrove KJ; Rosewell I; Moita LF; Stamp G; Turley SJ; Sahai E; Reis e Sousa C
    Nature; 2014 Oct; 514(7523):498-502. PubMed ID: 25341788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2.
    Tamura S; Suzuki-Inoue K; Tsukiji N; Shirai T; Sasaki T; Osada M; Satoh K; Ozaki Y
    Blood; 2016 Mar; 127(13):1701-10. PubMed ID: 26796360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice.
    Tang C; Wang L; Sheng Y; Zheng Z; Xie Z; Wu F; You T; Ren L; Xia L; Ruan C; Zhu L
    Theranostics; 2021; 11(20):9791-9804. PubMed ID: 34815786
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLEC-2 induced signalling in blood platelets].
    Martyanov AA; Kaneva VN; Panteleev MA; Sveshnikova AN
    Biomed Khim; 2018 Sep; 64(5):387-396. PubMed ID: 30378555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-endothelial cell-derived S1P regulates dendritic cell localization and vascular integrity in the lymph node.
    Simmons S; Sasaki N; Umemoto E; Uchida Y; Fukuhara S; Kitazawa Y; Okudaira M; Inoue A; Tohya K; Aoi K; Aoki J; Mochizuki N; Matsuno K; Takeda K; Miyasaka M; Ishii M
    Elife; 2019 Oct; 8():. PubMed ID: 31570118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLEC-2 stimulates IGF-1 secretion from podoplanin-positive stromal cells and positively regulates erythropoiesis in mice.
    Otake S; Sasaki T; Shirai T; Tsukiji N; Tamura S; Takano K; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2021 Jun; 19(6):1572-1584. PubMed ID: 33774924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type lectin-like receptor 2 (CLEC-2)-dependent dendritic cell migration is controlled by tetraspanin CD37.
    de Winde CM; Matthews AL; van Deventer S; van der Schaaf A; Tomlinson ND; Jansen E; Eble JA; Nieswandt B; McGettrick HM; Figdor CG; Tomlinson MG; Acton SE; van Spriel AB
    J Cell Sci; 2018 Oct; 131(19):. PubMed ID: 30185523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.
    Tanaka K; Tanaka M; Watanabe N; Ito M; Pastan I; Koizumi M; Matsusaka T
    Sci Rep; 2022 Dec; 12(1):22356. PubMed ID: 36572741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture.
    Astarita JL; Cremasco V; Fu J; Darnell MC; Peck JR; Nieves-Bonilla JM; Song K; Kondo Y; Woodruff MC; Gogineni A; Onder L; Ludewig B; Weimer RM; Carroll MC; Mooney DJ; Xia L; Turley SJ
    Nat Immunol; 2015 Jan; 16(1):75-84. PubMed ID: 25347465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
    Chang YW; Hsieh PW; Chang YT; Lu MH; Huang TF; Chong KY; Liao HR; Cheng JC; Tseng CP
    Oncotarget; 2015 Dec; 6(40):42733-48. PubMed ID: 26528756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets.
    Pan Y; Yago T; Fu J; Herzog B; McDaniel JM; Mehta-D'Souza P; Cai X; Ruan C; McEver RP; West C; Dai K; Chen H; Xia L
    Blood; 2014 Dec; 124(24):3656-65. PubMed ID: 25336627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.